Binder Biomedical, Inc. Announces Official Launch of the NEWTON(TM) Intervertebral Body Fusion Spinal Spacer System

BOCA RATON, Fla., Aug. 19 /PRNewswire/ -- The NEWTON Intervertebral Body Spacer System is comprised of a complete line of lumbar spinal spacers that allow anterior, posterior or lateral insertion angles to reach the intervertebral disc space. Each implant is designed with a large central window for optimum graft placement. Initial size offerings range from 7 to 15mm high and 7 to 45mm wide in both parallel and lordotic configurations. Through the use of a minimal-exposure patent-pending tube system, the NEWTON devices are implanted into the intervertebral space to provide stabilization and facilitate fusion. Lawrence Binder, President of Binder Biomedical, Inc. (BBI) stated, "Given the implant size ranges and instruments offered, the NEWTON system gives surgeons the option of a less invasive approach to treat patients, where traditional instrumentation may require a longer, more traumatic surgery."

The NEWTON System is manufactured using the PEEK-OPTIMA® polymer from Invibio Biomaterial Solutions. BBI has entered a supply assurance agreement with Invibio, the leader in orthopedic biomaterials, to provide its proprietary PEEK-OPTIMA® polymer for use in the NEWTON devices. All devices are manufactured in FDA registered facilities located in the USA.

By incorporating a unique approach to rapid product development, BBI combines clinical feedback and industry experience to offer continuous streamlined product improvements to the spine market. This Alpha launch of the NEWTON system will be followed with a full launch expected by the fourth quarter 2010. For more information on Binder Biomedical, Inc. and the NEWTON system please contact: sales@bindermed.com.

Binder Biomedical, Inc. is a privately held medical device company located in Boca Raton, Florida. Founded on the basis of combining quality engineering with surgeon innovation, the company provides surgeons with the highest quality medical devices for the treatment of complex orthopedic and neurological spinal disorders. Their development efforts are concentrated on products which incorporate advanced minimal exposure techniques, with the goal of providing better overall patient care. For more information about Binder Biomedical, Inc. please visit their website at: www.bindermed.com.

SOURCE Binder Biomedical, Inc.